Payment overview · 2025
General Payments
$135.08
2 reported records · 2 companies
Healthcare provider profile · identity verified
German G Lasala, MD
Allopathic & Osteopathic Physicians|Internal Medicine · TUCSON, AZ · NPI 1124086392
Verified facts
What the public records show
CMS Open Payments records show German G Lasala, MD received $135.08 in general payments during 2025 across 2 reported records.
Stryker Corporation accounted for 90.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $121.51 | 90.0% | 1 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $13.57 | 10.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $135.08 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $121.51 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $121.51 | 1 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $13.57 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 241 | 63 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 235 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 210 | 57 |
| Atorvastatin Calcium | Atorvastatin Calcium | 176 | 49 |
| Gabapentin | Gabapentin | 155 | 43 |
| Losartan Potassium | Losartan Potassium | 133 | 37 |
| Mounjaro | Tirzepatide | 116 | 18 |
| Lisinopril | Lisinopril | 109 | 29 |
| Pantoprazole Sodium | Pantoprazole Sodium | 97 | 29 |
| Azithromycin | Azithromycin | 85 | 63 |
| Montelukast Sodium | Montelukast Sodium | 77 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 75 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 74 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 73 | 19 |
| Progesterone | Progesterone, Micronized | 72 | 16 |
| Synthroid | Levothyroxine Sodium | 72 | 16 |
| Sertraline Hcl | Sertraline Hcl | 71 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 69 | 18 |
| Metoprolol Succinate | Metoprolol Succinate | 65 | 22 |
| Metformin Hcl Er | Metformin Hcl | 63 | 19 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 60 | 18 |
| Prednisone | Prednisone | 55 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 53 | 16 |
| Famotidine | Famotidine | 53 | 13 |
| Simvastatin | Simvastatin | 51 | 16 |
| Ezetimibe | Ezetimibe | 50 | 17 |
| Paxlovid | Nirmatrelvir/Ritonavir | 49 | 44 |
| Eliquis | Apixaban | 48 | 17 |
| Potassium Chloride | Potassium Chloride | 48 | 14 |
| Baclofen | Baclofen | 47 | 11 |
| Estradiol (Once Weekly) | Estradiol | 46 | suppressed |
| Ozempic | Semaglutide | 45 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 45 | 13 |
| Estradiol | Estradiol | 44 | 13 |
| Omeprazole | Omeprazole | 42 | 12 |
| Finasteride | Finasteride | 41 | 11 |
| Meloxicam | Meloxicam | 41 | 17 |
| Nebivolol Hcl | Nebivolol Hcl | 39 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 39 | suppressed |
| Alprazolam | Alprazolam | 37 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 37 | 13 |
| Farxiga | Dapagliflozin Propanediol | 36 | suppressed |
| Metformin Hcl | Metformin Hcl | 36 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 26 |
| Repatha Sureclick | Evolocumab | 36 | suppressed |
| Allopurinol | Allopurinol | 35 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 35 | 21 |
| Bupropion Xl | Bupropion Hcl | 34 | 11 |
| Fluconazole | Fluconazole | 34 | 14 |
| Lorazepam | Lorazepam | 34 | 12 |
| Ondansetron Odt | Ondansetron | 34 | 18 |
| Furosemide | Furosemide | 33 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 33 | suppressed |
| Testosterone | Testosterone | 33 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 30 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 29 | suppressed |
| Pregabalin | Pregabalin | 29 | suppressed |
| Celecoxib | Celecoxib | 28 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 28 | suppressed |
| Indapamide | Indapamide | 28 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 28 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 27 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 27 | 12 |
| Carvedilol | Carvedilol | 25 | suppressed |
| Gemtesa | Vibegron | 25 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 25 | suppressed |
| Methylprednisolone | Methylprednisolone | 25 | 21 |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Telmisartan | Telmisartan | 25 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 12 |
| Methocarbamol | Methocarbamol | 24 | suppressed |
| Amoxicillin | Amoxicillin | 22 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 22 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 22 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 22 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 15 |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 18 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Spironolactone | Spironolactone | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 17 | suppressed |
| Minoxidil | Minoxidil | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Atenolol | Atenolol | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Mirtazapine | Mirtazapine | 16 | suppressed |
| Np Thyroid | Thyroid,pork | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Memantine Hcl | Memantine Hcl | 15 | suppressed |
| Temazepam | Temazepam | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Clozapine | Clozapine | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Jardiance | Empagliflozin | 13 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Latanoprost | Latanoprost | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 13 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 13 | suppressed |
| Rivastigmine | Rivastigmine | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Xtampza Er | Oxycodone Myristate | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Armodafinil | Armodafinil | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $135.08 · 2 records | Stryker Corporation | CT THROMBECTOMY SYSTEM KIT, FLOWTRIEVER CATHETER, S, Veozah | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error